
Deep Longevity Selected by Kickstart as One of the Most Promising Start-ups in the World Discussing Proof of Concepts with Big Insurance and Health and Wellbeing Companies
Endurance RP Limited’s (“Endurance Longevity” or the “Company” and together with its subsidiaries, the “Group”; stock code: 0575.HK) wholly owned subsidiary Deep Longevity, Inc, a Hong Kong-based AI innovator and a leading provider of deep biomarkers of aging and longevity is pleased to announce that Deep Longevity was selected under Kickstart’s innovation 2022 accelerator programme as one of the 43 most promising start-ups/scaleups amongst 1,500+ applications from over 55 countries around the world.










